Bicycle Therapeutics (BCYC) Gains from Investment Securities (2018 - 2019)

Bicycle Therapeutics (BCYC) posted Gains from Investment Securities of -$19000.0 for Q4 2019, down 100.86% on a QoQ basis from $2.2 million in Q2 2019, and up 97.65% year-over-year from -$9613.2 in Q4 2018.

Bicycle Therapeutics (BCYC) Gains from Investment Securities (2018 - 2019) Analysis & Trends

Bicycle Therapeutics' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$19000.0 for Q4 2019.

  • Quarterly Gains from Investment Securities rose 97.65% year-over-year to -$19000.0 in Q4 2019, while the trailing twelve-month figure through Sep 2020 was -$19000.0 (down 100.41% YoY) and the FY2019 annual result came in at $5.4 million, up 709.17% from the prior year.
  • Gains from Investment Securities was -$19000.0 for Q4 2019 at Bicycle Therapeutics, down from $2.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $3.2 million in Q1 2019 and bottomed at -$807000.0 in Q4 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Bicycle Therapeutics 276.29 Mn 276.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 -19,000.00
Dec 31, 2019 -19,000.00
Jun 30, 2019 2.20 Mn
Jun 30, 2019 2.20 Mn
Mar 31, 2019 3.20 Mn
Mar 31, 2019 3.20 Mn
Dec 31, 2018 -807,000.00
Dec 31, 2018 -807,000.00
Sep 30, 2018 1.36 Mn
Sep 30, 2018 1.36 Mn